...
首页> 外文期刊>Sao Paulo Medical Journal >Malignant catatonia responsive to low doses of lorazepam: case report
【24h】

Malignant catatonia responsive to low doses of lorazepam: case report

机译:低剂量劳拉西m对恶性卡他顿的反应:病例报告

获取原文
           

摘要

AbstractCONTEXT: Catatonia can be divided into non-malignant or malignant. The latter is characterized by autonomic instability, exhibiting high fever, tachycardia and hypertension, and is regarded as a fulminant and rapidly progressive subtype.CASE REPORT: This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years. The patient was stable, maintaining mutism, immobility and autonomic abnormalities. Oral lorazepam (1 mg every eight hours) was introduced and, in a few hours, the patient became afebrile. Two days later, the patient was already responding to verbal commands.CONCLUSIONS: Early intervention with lorazepam reduced the evolution of this patient to a fatal complication. Therefore, this case report sought to show that early diagnosis and intervention reduced the occurrence of serious and irreversible clinical outcomes.
机译:摘要背景:卡塔尼亚病可分为非恶性或恶性的。后者的特点是自主神经不稳定,表现出高烧,心动过速和高血压,被认为是暴发性和快速进行性亚型。病例报告:本文报道了一名43岁的恶性卡塔尼亚患者最近三年的精神疾病。病人稳定,保持ism默,不动和自主神经异常。口服劳拉西m(每八小时1毫克),数小时后患者发热。两天后,患者已经对口头命令作出反应。结论:劳拉西m的早期干预使该患者的发展成为致命的并发症。因此,该病例报告试图显示早期诊断和干预措施减少了严重且不可逆的临床结果的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号